CYP2C8 (cytochrome P450 family 2 subfamily C member 8)

2003-06-01  

Identity

HGNC
LOCATION
10q23.33
LOCUSID
ALIAS
CPC8,CYP2C8DM,CYPIIC8,MP-12/MP-20

Other Information

Locus ID:

NCBI: 1558
MIM: 601129
HGNC: 2622
Ensembl: ENSG00000138115

Variants:

dbSNP: 1558
ClinVar: 1558
TCGA: ENSG00000138115
COSMIC: CYP2C8

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000138115ENST00000371270P10632
ENSG00000138115ENST00000490994E9PLI9
ENSG00000138115ENST00000525991E9PIW6
ENSG00000138115ENST00000527420G3V188
ENSG00000138115ENST00000535898P10632
ENSG00000138115ENST00000539050B7Z1F5
ENSG00000138115ENST00000623108B7Z1F5
ENSG00000138115ENST00000628935A0A0D9SG51

Expression (GTEx)

0
100
200
300
400
500
600
700

Pathways

PathwaySourceExternal ID
Arachidonic acid metabolismKEGGko00590
Linoleic acid metabolismKEGGko00591
Retinol metabolismKEGGko00830
Drug metabolism - cytochrome P450KEGGko00982
Arachidonic acid metabolismKEGGhsa00590
Linoleic acid metabolismKEGGhsa00591
Retinol metabolismKEGGhsa00830
Drug metabolism - cytochrome P450KEGGhsa00982
Metabolic pathwaysKEGGhsa01100
Serotonergic synapseKEGGhsa04726
Chemical carcinogenesisKEGGhsa05204
Chemical carcinogenesisKEGGko05204
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Arachidonic acid metabolismREACTOMER-HSA-2142753
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)REACTOMER-HSA-2142816
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)REACTOMER-HSA-2142670
Biological oxidationsREACTOMER-HSA-211859
Phase 1 - Functionalization of compoundsREACTOMER-HSA-211945
Cytochrome P450 - arranged by substrate typeREACTOMER-HSA-211897
XenobioticsREACTOMER-HSA-211981
CYP2E1 reactionsREACTOMER-HSA-211999

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA10235zoledronateChemicalClinicalAnnotationassociatedPD18594024
PA128406954Weight gainDiseaseVariantAnnotationambiguousPD27271184
PA128406956fluorouracilChemicalClinicalAnnotationassociatedPD
PA133950441hmg coa reductase inhibitorsChemicalPathwayassociated
PA164712563BisphosphonatesChemicalClinicalAnnotation, VariantAnnotation, VipGeneambiguousPD21396799, 18594024
PA164712580Calcineurin inhibitorsChemicalVariantAnnotationassociatedPD23426640
PA164746311everolimusChemicalVariantAnnotationnot associatedPD23797529
PA164748728mycophenolic acidChemicalPathway, VipGeneassociated22572835, 24220207
PA164925725Toxic liver diseaseDiseaseVariantAnnotationambiguousPD17241877, 25504632
PA165291492pazopanibChemicalVariantAnnotationassociatedPD25504632
PA165817016Kidney TransplantationDiseaseClinicalAnnotation, VariantAnnotationassociatedPKPD18769365, 23426640, 24681964, 28316087
PA165958682CYP2C8*1BHaplotypeVipGeneassociated17923851, 12429347
PA165958683CYP2C8*1CHaplotypeVipGeneassociated12429347
PA165958684CYP2C8*2HaplotypeVipGeneassociated17361129, 20459297, 23536207, 11668219
PA165958685CYP2C8*3HaplotypeVipGeneassociated11767116, 12429347, 12435384, 12530467, 12756196, 15655291, 15900280, 16164496, 17361129, 17923851, 19614891, 20421446, 20459297, 20665013, 23536207, 11668219
PA165958686CYP2C8*4HaplotypeVipGeneassociated17923851, 18574320, 20459297, 20848147, 23536207, 12429347
PA166114458heart transplantationDiseaseVariantAnnotationnot associatedPD23797529
PA166122590simeprevirChemicalLabelAnnotationassociated
PA166131631glomerular filtration rateDiseaseVariantAnnotationassociated28316087
PA166153431flibanserinChemicalLabelAnnotationassociated
PA166153961rs1058930VariantVipGeneassociated17923851, 18574320, 20459297, 20848147, 23536207, 12429347
PA166154085rs7909236VariantVipGeneassociated17923851, 12429347
PA166154110rs10509681VariantVipGeneassociated11767116, 12429347, 12435384, 12530467, 12756196, 15655291, 15900280, 16164496, 17361129, 17923851, 19614891, 20421446, 20459297, 20665013, 23536207, 11668219
PA166154140rs11572080VariantVipGeneassociated11767116, 12429347, 12435384, 12530467, 12756196, 15655291, 15900280, 16164496, 17361129, 17923851, 19614891, 20421446, 20459297, 20665013, 23536207, 11668219
PA166154141rs11572103VariantVipGeneassociated17361129, 20459297, 23536207, 11668219
PA166154160rs17110453VariantVipGeneassociated12429347
PA166163418rucaparibChemicalLabelAnnotationassociated
PA166163692diclofenac acyl glucuronideChemicalVariantAnnotationassociatedPK29203276
PA378NR1I2GenePathwayassociated21151855
PA443450AsthmaDiseaseClinicalAnnotationassociatedPK28940478
PA443560Breast NeoplasmsDiseaseClinicalAnnotation, VariantAnnotationambiguousPKPD24599932, 25495407, 30520341
PA443622Carcinoma, Non-Small-Cell LungDiseaseClinicalAnnotationassociatedPD31616045
PA443886Diabetes MellitusDiseaseVariantAnnotationambiguousPD27271184
PA443937Drug ToxicityDiseaseClinicalAnnotationassociatedPD20212519
PA444682Kidney DiseasesDiseaseVariantAnnotationambiguousPD
PA444985Multiple MyelomaDiseaseClinicalAnnotation, VariantAnnotationambiguousPD18594024
PA445113NeutropeniaDiseaseClinicalAnnotationassociatedPD
PA445187OsteonecrosisDiseaseClinicalAnnotation, VariantAnnotationambiguousPD18594024
PA445204Ovarian NeoplasmsDiseaseVariantAnnotationambiguousPKPD20368717, 21327421
PA445301Peripheral Nervous System DiseasesDiseaseVariantAnnotationambiguousPD24599932, 26115084
PA445846ThrombocytopeniaDiseaseClinicalAnnotationassociatedPD31616045
PA446975Neurotoxicity SyndromesDiseaseClinicalAnnotationassociatedPD20212519
PA447247liver transplantationDiseaseVariantAnnotationambiguousPD
PA448404amodiaquineChemicalClinicalAnnotation, Pathway, VariantAnnotation, VipGeneassociatedPKPD21998472, 23204183, 17361129, 18855526
PA448500atorvastatinChemicalPathwayassociated
PA448785carbamazepineChemicalPathwayassociated21738081
PA448803carboplatinChemicalClinicalAnnotation, VariantAnnotationambiguousPD21327421, 31616045
PA448871celecoxibChemicalVariantAnnotationnot associatedPK23996211
PA448897cerivastatinChemicalVariantAnnotation, VipGeneassociatedPK15365880, 11844864
PA449053clopidogrelChemicalLiterature, MultilinkAnnotationassociated24971633
PA449165cyclophosphamideChemicalClinicalAnnotation, VariantAnnotationambiguousPD24599932
PA449167cyclosporineChemicalVariantAnnotationambiguousPD23426640
PA449293diclofenacChemicalClinicalAnnotation, VariantAnnotationambiguousPKPD17241877, 18548238, 29203276
PA449412doxorubicinChemicalVariantAnnotationnot associatedPD
PA449476epirubicinChemicalClinicalAnnotation, VariantAnnotationambiguousPD24599932
PA449688fluvastatinChemicalPathwayassociated
PA449748gemcitabineChemicalClinicalAnnotationassociatedPD31616045
PA449957ibuprofenChemicalClinicalAnnotation, Pathway, VariantAnnotation, VipGeneassociatedPKPD18216720, 18694831, 19480553, 15289789, 18694831, 19480553, 25502615, 26122864, 30562214
PA450272lovastatinChemicalPathwayassociated
PA450546montelukastChemicalClinicalAnnotation, VariantAnnotationassociatedPK28940478
PA450566mycophenolate mofetilChemicalClinicalAnnotationassociatedPD24681964
PA450761paclitaxelChemicalClinicalAnnotation, Pathway, VariantAnnotation, VipGeneambiguousPKPD17224914, 17925548, 19143748, 20212519, 20368717, 22527201, 23215890, 11668219, 11767116, 12429347, 16299241, 18574320, 20212519, 20368717, 21151855, 21327421, 24599932, 25495407, 25504632, 26115084, 30520341
PA450767pamidronateChemicalClinicalAnnotationassociatedPD18594024
PA450970pioglitazoneChemicalClinicalAnnotation, VariantAnnotation, VipGeneambiguousPKPD17913194, 23370354, 17178266, 22625877, 23712614, 27271184
PA451234repaglinideChemicalClinicalAnnotation, Pathway, VariantAnnotation, VipGeneassociatedPKPD15961978, 18388877, 21270106, 14534525, 17923851
PA451283rosiglitazoneChemicalClinicalAnnotation, Pathway, VariantAnnotation, VipGeneassociatedPKPD23426382, 17178266, 23426382, 27271184
PA451363simvastatinChemicalPathway, VariantAnnotationassociatedPD25504632
PA451578tacrolimusChemicalClinicalAnnotation, VariantAnnotationassociatedPKPD18769365, 23426640, 28316087
PA7000sorafenibChemicalPathwayassociated28362716

References

Pubmed IDYearTitleCitations
197068582009Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.307
198332602009The SLCO1B1*5 genetic variant is associated with statin-induced side effects.116
165381762006Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.112
170480072007Association of warfarin dose with genes involved in its action and metabolism.100
199131212009Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.85
146761962004Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site.82
116682192001Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.76
163854512006A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.69
179751192008Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study.65
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.62

Citation

Dessen P

CYP2C8 (cytochrome P450 family 2 subfamily C member 8)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/40244/cyp2c8